Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

Maria Stamouli, Ioannis Tsonis, MD, Konstantinos Gkirkas, Christina Economopoulou, Thomas Thomopoulos, MD, Anna Paisiou, MD, Nikolaos Siafakas, Spyridon Pournaras, Anastasia Antoniadou, Aggeliki Karagiannidi, Joseph Meletiadis, Dimitra Kavatha, George Vassilopoulos, MD PhD, Stavros Gigantes, MD, Ioannis Baltadakis, MD, Evgenios Goussetis, Dimitrios Karakasis, MD, Panagiotis Tsirigotis

Blood (2019) 134 (Supplement_1): 4498.

https://doi.org/10.1182/blood-2019-128362

Published: 2019

Journal Articles

Caplacizumab As Step-up Therapy in Refractory TTP Utilizing Adamts-13 Activity and Evidence of End-Organ Damage

Neel Belani, MD, Adriel Barrios-Anderson, Sc.B, A.B., William Rafelson, MDMBA, Matthew I. Quesenberry, MD, Rabin Niroula, MBBS

Blood (2019) 134 (Supplement_1): 4909.

https://doi.org/10.1182/blood-2019-123206

Published: 2019

Journal Articles

Identifying Novel Immunodominant Epitopes within Human Parainfluenza Virus-3 Matrix Protein

Katherine Marie Harris, MD, Michael Keller, MD, Catherine M. Bollard, MD, Sarah Horn, BA, Christopher Lazarski, PhD, Gelina Sani, MS

Blood (2019) 134 (Supplement_1): 3251.

https://doi.org/10.1182/blood-2019-131898

Published: 2019

Journal Articles

Rapid Generation of Multivirus-Specific T Lymphocytes for the Prevention and Treatment of Respiratory Viral Infections

Spyridoula Vasileiou, PhD, Annie Turney, Manik Kuvalekar, Shivani Mukhi, Ayumi Watanabe, Premal Lulla, MBBS, Carlos A. Ramos, MD, Juan Vera, MD, Ifigeneia Tzannou, MD, Ann Leen, PhD

Blood (2018) 132 (Supplement 1): 3332.

https://doi.org/10.1182/blood-2018-99-113168

Published: 2018

Journal Articles

A Phase I Trial of iPSC-Derived MSCs (CYP-001) in Steroid-Resistant Acute GvHD

Adrian Bloor, MA MB BChir PhD FCRP FRCPath, Amit Patel, MBBS, PhD MRCP(Lond), MRCS(Eng), MAcadMEd, FFICM, FRCPath, James E Griffin, BSc (Hons), MBChB (Hons), PhD, Maria H Gilleece, MD FRCPath, MB, BSc, FRCP, Rohini Radia, MD FRCPath, David T Yeung, PhD BSc, FRACP, FRCPA, MBBS, Igor Slukvin, MD PhD, Kilian Kelly, PhD, John E.J. Rasko, MBBS, PhD

Blood (2018) 132 (Supplement 1): 4562.

https://doi.org/10.1182/blood-2018-99-110432

Published: 2018

Journal Articles

Interim Results from the Phase 1a/1b Dose-Finding Study of CWP232291 (CWP291) in Relapsed or Refractory Myeloma (RRMM) Alone or in Combination with Lenalidomide and Dexamethasone

Elisabet E. Manasanch, MD, Sung-Soo Yoon, MD PhD, Chang-Ki Min, MD, Jin Seok Kim, MD PhD, Kenneth H Shain, MD PhD, Robert Hauptschein, MDPhD, Jeongeun E Choi, PhD, Kyoung-June Lee

Blood (2017) 130 (Supplement 1): 3091.

https://doi.org/10.1182/blood.V130.Suppl_1.3091.3091

Published: 2017

Journal Articles

Extra-Corporeal Photopheresis Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Efficacy, Safety and Immune Correlates

John Koreth, MBBS, DPhil, Haesook T Kim, PhD, Roger Belizaire, MD PhD, Samuel J Poryanda, BSc, Carol Reynolds, PhD, Jennifer Whangbo, MD PhD, Sarah Nikiforow, Edwin Alyea, III, MD, Philippe Armand, MD PhD, Corey Cutler, MD MPH, FRCPC, Vincent T Ho, MD, Bruce Blazar, MD, Joseph H. Antin, MD, Jerome Ritz, MD, Robert J. Soiffer, MD

Blood (2017) 130 (Supplement 1): 515.

https://doi.org/10.1182/blood.V130.Suppl_1.515.515

Published: 2017

Journal Articles

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

Blood (2017) 130 (Supplement 1): 340.

https://doi.org/10.1182/blood.V130.Suppl_1.340.340

Published: 2017

Journal Articles

Parainfluenza Virus Infections in Patients with Hematologic Malignancies or Following Stem Cell Transplantation: Analysis of Clinical Characteristics, Nosocomial Transmission and Prolonged Viral Shedding

Nicola Lehners, MD, Joe Puthenparambil, MD, Martin Schiller, MD, Anthony D. Ho, MD, Paul Schnitzler, MD, Gerlinde Egerer, MD

Blood (2016) 128 (22): 3401.

https://doi.org/10.1182/blood.V128.22.3401.3401

Published: 2016

Journal Articles

Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial

Blood (2016) 128 (22): 500.

https://doi.org/10.1182/blood.V128.22.500.500

Published: 2016

Journal Articles

Improved Survival of High Risk Patients with Parainfluenza Virus Following Hematopoietic Cell Transplantation: Role of Aerosolized Ribavirin

Isabelle T Nguyen, BSc, MSc, Sumana Shashidhar, BSc, MSc, MA, Janice (Wes) M. Brown, MD

Blood (2016) 128 (22): 5803.

https://doi.org/10.1182/blood.V128.22.5803.5803

Published: 2016

Journal Articles

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Mark Vander Lugt, MD, Hey Jin Chong, MD PhD, Xiaohua Chen, MDPhD, Randy M. Windreich, MD, Rakesh Goyal, MD MRCP, Maria Escolar, MD, Paul Szabolcs, MD

Blood (2015) 126 (23): 4329.

https://doi.org/10.1182/blood.V126.23.4329.4329

Published: 2015

Journal Articles

Upper and Lower Respiratory Tract Infections By Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Erden Atilla, MD, Pinar Ataca, MD, Didem Sahin, MD, Pervin Topcuoglu, MD, Istar Dolapci, MD, Alper Tekeli, MD, Selami Kocak Toprak, MD, Sinem Civriz Bozdag, MD, Meltem Kurt Yuksel, MD, Muhit Ozcan, MD, Gunhan Gurman, MD

Blood (2015) 126 (23): 5479.

https://doi.org/10.1182/blood.V126.23.5479.5479

Published: 2015

Journal Articles

Phase I Trial of IL-21 Ex Vivo Expanded NK Cells Administration to Prevent Disease Relapse after Haploidentical Stem-Cell Transplantation for Myeloid Leukemias

Stefan O. Ciurea, MD, Dean A. Lee, MD PhD, Kai Cao, MS, MD, Gabriela Rondon, MD, Julianne Chen, Dana B. Willis, Sairah Ahmed, MD, Eric Yvon, PhD, Katayoun Rezvani, MDPhD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD

Blood (2015) 126 (23): 102.

https://doi.org/10.1182/blood.V126.23.102.102

Published: 2015

Journal Articles

Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation: Comparison with Viral Infectious Pneumonia

Sachiko Seo, MD PhD, Jeffrey Yu, Isaac C Jenkins, MS, Terry L Stevens-Ayers, MS, Kuypers M Jane, PhD, Huang Meei-Li, PhD, Wendy M Leisenring, PhD, Keith R Jerome, MD PhD, Sophie Paczesny, MD PhD, Michael Boeckh, MD

Blood (2015) 126 (23): 1927.

https://doi.org/10.1182/blood.V126.23.1927.1927

Published: 2015

Journal Articles

Final Results from a Phase 2 Study of Pracinostat in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)

Guillermo Garcia-Manero, MD, Ehab Atallah, MD, Samer K Khaled, MD, Martha Arellano, Mrinal M Patnaik, MBBS, Todd A Butler, Carla Ashby, Bruno C. Medeiros, MD

Blood (2015) 126 (23): 453.

https://doi.org/10.1182/blood.V126.23.453.453

Published: 2015

Journal Articles

Respiratory Infections and Activity of Anti-Flu Vaccine in Patients with Lymphoma and Multiple Myeloma

Noa Lavi, MD, Emilia Hardak, MD, Ilana Oren, MD, Irit Avivi, MD

Blood (2015) 126 (23): 4617.

https://doi.org/10.1182/blood.V126.23.4617.4617

Published: 2015

Journal Articles

Epidemiology and Outcomes of Respiratory Virus Infections in Adult Acute Leukemia and Hematopoietic Stem Cell Transplant Patients

Gaurav Trikha, MBBS, MD, Rebecca Conway, BSN, John W Hiemenz, MD, Per T. Ljungman, MD PhD

Blood (2014) 124 (21): 4984.

https://doi.org/10.1182/blood.V124.21.4984.4984

Published: 2014

Journal Articles

Incidence and Predictors of Respiratory Viral Infections By Multi-Plex PCR in Allogeneic Hematopoietic Cell Transplant (HCT) Recipients 50 Years and Older Including Geriatric Assessment (GA)

Christopher R D'Angelo, MD, Masha Kocherginsky, PhD, Michael R Bishop, MD, Lucy A Godley, MD PhD, Justin Kline, MD, Richard A. Larson, Hongtao Liu, MD PhD, Olatoyosi Odenike, MD, Jennifer Pisano, MD, Wendy Stock, MD, Andrew Artz, MD MS

Blood (2014) 124 (21): 2464.

https://doi.org/10.1182/blood.V124.21.2464.2464

Published: 2014

Journal Articles

Secondary Hemophagocytic Syndrome

Vinicius R. P. Mattos, MD, Michelle P. Silveira, MD, Flávia M. Ferreira, MD, Dirceu H. C. Campelo, MD, Juliano Cordova Vargas, MD, Clarissa L.M. Souza, MD, Nelson Hamerschlak, MD PhD, Fabio P S Santos, MD, Paulo A. A. Silveira, MD PhD

Blood (2014) 124 (21): 4958.

https://doi.org/10.1182/blood.V124.21.4958.4958

Published: 2014

NARROW

Oral Ribavirin with or without the Addition of Immune Globulin for the Treatment of Lower Respiratory Tract Infections Due to Respiratory Syncytial Virus or Parainfluenza in Patients after Allogeneic Stem Cell Transplantation

Caplacizumab As Step-up Therapy in Refractory TTP Utilizing Adamts-13 Activity and Evidence of End-Organ Damage

Identifying Novel Immunodominant Epitopes within Human Parainfluenza Virus-3 Matrix Protein

Rapid Generation of Multivirus-Specific T Lymphocytes for the Prevention and Treatment of Respiratory Viral Infections

A Phase I Trial of iPSC-Derived MSCs (CYP-001) in Steroid-Resistant Acute GvHD

Interim Results from the Phase 1a/1b Dose-Finding Study of CWP232291 (CWP291) in Relapsed or Refractory Myeloma (RRMM) Alone or in Combination with Lenalidomide and Dexamethasone

Extra-Corporeal Photopheresis Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Efficacy, Safety and Immune Correlates

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

Parainfluenza Virus Infections in Patients with Hematologic Malignancies or Following Stem Cell Transplantation: Analysis of Clinical Characteristics, Nosocomial Transmission and Prolonged Viral Shedding

Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial

Improved Survival of High Risk Patients with Parainfluenza Virus Following Hematopoietic Cell Transplantation: Role of Aerosolized Ribavirin

Excellent Outcomes in Children and Young Adults Using Reduced-Intensity Conditioning for Patients with Inborn Errors of Immunity, Hematopoiesis, and Metabolism with Single-Unit Cord Blood or Bone Marrow

Upper and Lower Respiratory Tract Infections By Respiratory Viruses in Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)

Phase I Trial of IL-21 Ex Vivo Expanded NK Cells Administration to Prevent Disease Relapse after Haploidentical Stem-Cell Transplantation for Myeloid Leukemias

Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation: Comparison with Viral Infectious Pneumonia

Final Results from a Phase 2 Study of Pracinostat in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)

Respiratory Infections and Activity of Anti-Flu Vaccine in Patients with Lymphoma and Multiple Myeloma

Epidemiology and Outcomes of Respiratory Virus Infections in Adult Acute Leukemia and Hematopoietic Stem Cell Transplant Patients

Incidence and Predictors of Respiratory Viral Infections By Multi-Plex PCR in Allogeneic Hematopoietic Cell Transplant (HCT) Recipients 50 Years and Older Including Geriatric Assessment (GA)

Secondary Hemophagocytic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only